This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Dec;174(12):1753-1754.

doi: 10.7326/M21-3903. Epub 2021 Oct 26.

Managing HIV Treatment Failure: Time to REVAMP?

Roy M Gulick¹, Marshall J Glesby¹

Affiliations

PMID: 34698505
DOI: 10.7326/M21-3903

Editorial

Managing HIV Treatment Failure: Time to REVAMP?

Roy M Gulick et al. Ann Intern Med. 2021 Dec.

. 2021 Dec;174(12):1753-1754.

doi: 10.7326/M21-3903. Epub 2021 Oct 26.

Authors

Roy M Gulick¹, Marshall J Glesby¹

Affiliation

¹ Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York.

PMID: 34698505
DOI: 10.7326/M21-3903

No abstract available

PubMed Disclaimer

Comment on

Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa : An Unblinded Randomized Controlled Trial.
Siedner MJ, Moosa MS, McCluskey S, Gilbert RF, Pillay S, Aturinda I, Ard K, Muyindike W, Musinguzi N, Masette G, Pillay M, Moodley P, Brijkumar J, Rautenberg T, George G, Gandhi RT, Johnson BA, Sunpath H, Bwana MB, Marconi VC. Siedner MJ, et al. Ann Intern Med. 2021 Dec;174(12):1683-1692. doi: 10.7326/M21-2229. Epub 2021 Oct 26. Ann Intern Med. 2021. PMID: 34698502 Free PMC article. Clinical Trial.

Similar articles

Funding. AIDS activists: CARE Act revamp imperils big cities' system of HIV care.
[No authors listed] [No authors listed] AIDS Policy Law. 2005 Aug 12;20(15):4. AIDS Policy Law. 2005. PMID: 16136683 No abstract available.
The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates.
Siedner MJ, Bwana MB, Moosa MS, Paul M, Pillay S, McCluskey S, Aturinda I, Ard K, Muyindike W, Moodley P, Brijkumar J, Rautenberg T, George G, Johnson B, Gandhi RT, Sunpath H, Marconi VC. Siedner MJ, et al. HIV Clin Trials. 2017 Jul;18(4):149-155. doi: 10.1080/15284336.2017.1349028. Epub 2017 Jul 18. HIV Clin Trials. 2017. PMID: 28720039 Free PMC article. Review.
Funding. Activists split on White House's revamp of Ryan White CARE Act.
[No authors listed] [No authors listed] AIDS Policy Law. 2005 Aug 12;20(15):1, 4. AIDS Policy Law. 2005. PMID: 16144054 No abstract available.
Preventing and managing resistance in the clinical setting.
Kuritzkes DR. Kuritzkes DR. J Acquir Immune Defic Syndr. 2003 Oct 1;34 Suppl 2:S103-10. doi: 10.1097/00126334-200310012-00002. J Acquir Immune Defic Syndr. 2003. PMID: 14703938 Review. No abstract available.
Antiretroviral therapy: treatment-experienced individuals.
Calvo KR, Daar ES. Calvo KR, et al. Infect Dis Clin North Am. 2014 Sep;28(3):439-56. doi: 10.1016/j.idc.2014.06.005. Epub 2014 Jul 8. Infect Dis Clin North Am. 2014. PMID: 25151565 Review.

See all similar articles

Cited by

HIV-1 prevalence, drug resistance, and associated factors in the urban Ethiopian population.
Deress T, Worede A, Birhanu A, Girma M. Deress T, et al. Sci Rep. 2025 May 17;15(1):17216. doi: 10.1038/s41598-025-02122-8. Sci Rep. 2025. PMID: 40382412 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information